MRNA COVID-19 Vaccine and Hope to Cure Cancer
DOI:
https://doi.org/10.3126/njc.v5i1.41363Keywords:
MRNA, COVID, Cancer VaccineAbstract
There is hope that cancer patient should benefit from mRNA COVID-19 vaccination. Some of the most advanced candidate vaccines are encapsulated in carriers of lipids, and small liposomes are expected to accumulate in tumor tissue through the enhanced effect of permeation and retention. However, the extent to which solid tumors might take a significant part of the vaccine dose, so it is still unknown. This requires a careful evaluation of these promising vaccines of mRNA COVID-19 managed as carriers of lipids for patients with solid tumors, including a possible revaluation of the assay for optimal protection of this specification and the fragile population.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nepalese Journal of Cancer
This work is licensed under a Creative Commons Attribution 4.0 International License.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as NJC and the authors are acknowledged.
Submission of the manuscript means that the authors agree to assign exclusive copyright to NJC. The aim of NJC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact.